Logo image of BLCT

BLUECITY HOLDINGS LTD-ADR (BLCT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BLCT - US09610L1061 - ADR

1.54 USD
0 (0%)
Last: 8/12/2022, 9:44:06 PM
1.54 USD
0 (0%)
After Hours: 8/12/2022, 9:44:06 PM
Fundamental Rating

3

BLCT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 70 industry peers in the Interactive Media & Services industry. While BLCT seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, BLCT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BLCT has reported negative net income.
BLCT Yearly Net Income VS EBIT VS OCF VS FCFBLCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -50.74%
ROE N/A
ROIC -34.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLCT Yearly ROA, ROE, ROICBLCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -18.65%
PM (TTM) -28.76%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLCT Yearly Profit, Operating, Gross MarginsBLCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 20 -20

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCT is destroying value.
Compared to 1 year ago, BLCT has about the same amount of shares outstanding.
BLCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BLCT Yearly Shares OutstandingBLCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 5M 10M 15M 20M
BLCT Yearly Total Debt VS Total AssetsBLCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -1.63, we must say that BLCT is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for BLCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.63
ROIC/WACC-3.56
WACC9.74%
BLCT Yearly LT Debt VS Equity VS FCFBLCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.08 indicates that BLCT has no problem at all paying its short term obligations.
BLCT has a Quick Ratio of 3.04. This indicates that BLCT is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 3.04
BLCT Yearly Current Assets VS Current LiabilitesBLCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for BLCT have decreased strongly by -35.98% in the last year.
Looking at the last year, BLCT shows a small growth in Revenue. The Revenue has grown by 4.39% in the last year.
Measured over the past years, BLCT shows a very strong growth in Revenue. The Revenue has been growing by 29.02% on average per year.
EPS 1Y (TTM)-35.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
Revenue 1Y (TTM)4.39%
Revenue growth 3Y29.02%
Revenue growth 5YN/A
Sales Q2Q%-12.63%

3.2 Future

BLCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.03% yearly.
BLCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.56% yearly.
EPS Next Y34.41%
EPS Next 2Y36.85%
EPS Next 3Y21.73%
EPS Next 5Y14.03%
Revenue Next Year16.48%
Revenue Next 2Y18.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.56%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BLCT Yearly Revenue VS EstimatesBLCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BLCT Yearly EPS VS EstimatesBLCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BLCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BLCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLCT Price Earnings VS Forward Price EarningsBLCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.2
BLCT Per share dataBLCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

BLCT's earnings are expected to grow with 21.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.85%
EPS Next 3Y21.73%

More info and screens

0

5. Dividend

5.1 Amount

BLCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUECITY HOLDINGS LTD-ADR

NASDAQ:BLCT (8/12/2022, 9:44:06 PM)

After market: 1.54 0 (0%)

1.54

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)07-29 2022-07-29
Earnings (Next)08-22 2022-08-22
Inst Owners8.07%
Inst Owner Change-31.61%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.80M
Revenue(TTM)1.08B
Net Income(TTM)-309.62M
Analysts43.33
Price Target2.04 (32.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB N/A
EV/EBITDA -0.2
EPS(TTM)-1.94
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.28
BVpS1.77
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.74%
ROE N/A
ROCE N/A
ROIC -34.64%
ROICexc N/A
ROICexgc -47.79%
OM -18.65%
PM (TTM) -28.76%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 3.04
Altman-Z -1.63
F-Score4
WACC9.74%
ROIC/WACC-3.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.77%
EPS Next Y34.41%
EPS Next 2Y36.85%
EPS Next 3Y21.73%
EPS Next 5Y14.03%
Revenue 1Y (TTM)4.39%
Revenue growth 3Y29.02%
Revenue growth 5YN/A
Sales Q2Q%-12.63%
Revenue Next Year16.48%
Revenue Next 2Y18.14%
Revenue Next 3Y17.36%
Revenue Next 5Y17.56%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BLUECITY HOLDINGS LTD-ADR / BLCT FAQ

What is the fundamental rating for BLCT stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCT.


What is the valuation status of BLUECITY HOLDINGS LTD-ADR (BLCT) stock?

ChartMill assigns a valuation rating of 2 / 10 to BLUECITY HOLDINGS LTD-ADR (BLCT). This can be considered as Overvalued.


Can you provide the profitability details for BLUECITY HOLDINGS LTD-ADR?

BLUECITY HOLDINGS LTD-ADR (BLCT) has a profitability rating of 1 / 10.


What is the expected EPS growth for BLUECITY HOLDINGS LTD-ADR (BLCT) stock?

The Earnings per Share (EPS) of BLUECITY HOLDINGS LTD-ADR (BLCT) is expected to grow by 34.41% in the next year.